Advanced Enzyme

57
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
315.00
9.2 (3.01%)
BSENSE

Jul 31, 03:30 PM

BSE+NSE Vol: 2.46 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
745.00
636.00
623.00
540.00
529.00
501.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
745.00
636.00
623.00
540.00
529.00
501.00
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-10.00
-10.00
4.00
-20.00
-1.00
Raw Materials Consumed
194.00
161.00
155.00
127.00
130.00
100.00
Power & Fuel Cost
44.00
38.00
41.00
38.00
29.00
21.00
Employee Cost
162.00
141.00
127.00
114.00
103.00
87.00
Operating Expenses
33.00
30.00
32.00
26.00
22.00
16.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
26.00
24.00
17.00
17.00
16.00
9.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
14.00
16.00
12.00
15.00
8.00
7.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
515.00
441.00
418.00
383.00
326.00
269.00
Operating Profit (PBDIT) excl Other Income
230.00
195.00
205.00
157.00
202.00
232.00
Other Income
34.00
33.00
36.00
25.00
6.00
8.00
Operating Profit (PBDIT)
265.00
228.00
242.00
182.00
208.00
241.00
Interest
3.00
4.00
4.00
3.00
2.00
2.00
Profit before Depriciation and Tax
261.00
223.00
238.00
179.00
206.00
238.00
Depreciation
40.00
36.00
35.00
35.00
34.00
28.00
Profit Before Taxation & Exceptional Items
221.00
187.00
202.00
144.00
171.00
210.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
232.00
187.00
187.00
140.00
171.00
210.00
Provision for Tax
58.00
53.00
50.00
36.00
47.00
58.00
Profit After Tax
173.00
133.00
136.00
103.00
123.00
151.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
1,153.00
1,079.00
1,002.00
907.00
797.00
657.00
Profit Available for appropriations
1,321.00
1,210.00
1,135.00
1,012.00
917.00
803.00
Appropriations
1,321.00
1,210.00
1,135.00
1,012.00
917.00
803.00
Equity Dividend (%)
267.50%
260.00%
255.00%
50.00%
50.00%
45.00%
Earnings Per Share
15.08
11.72
11.92
9.45
10.70
13.06
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 17.09% vs 2.09% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 17.73% vs -4.93% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -19.41% vs 12.40% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 29.58% vs -2.17% in Mar 2025

Compare Profit and Loss Results of Advanced Enzyme
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
745.00
835.00
-90.00
-10.78%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
52.00
-52.00
-100.00%
Net Sales
745.00
782.00
-37.00
-4.73%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-64.00
63.00
98.44%
Raw Materials Consumed
194.00
501.00
-307.00
-61.28%
Power & Fuel Cost
44.00
56.00
-12.00
-21.43%
Employee Cost
162.00
80.00
82.00
102.50%
Operating Expenses
33.00
29.00
4.00
13.79%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
26.00
13.00
13.00
100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
14.00
2.00
12.00
600.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
515.00
643.00
-128.00
-19.91%
Operating Profit (PBDIT) excl Other Income
230.00
138.00
92.00
66.67%
Other Income
34.00
6.00
28.00
466.67%
Operating Profit (PBDIT)
265.00
145.00
120.00
82.76%
Interest
3.00
18.00
-15.00
-83.33%
Profit before Depriciation and Tax
261.00
126.00
135.00
107.14%
Depreciation
40.00
34.00
6.00
17.65%
Profit Before Taxation & Exceptional Items
221.00
92.00
129.00
140.22%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
232.00
92.00
140.00
152.17%
Provision for Tax
58.00
24.00
34.00
141.67%
Profit After Tax
173.00
67.00
106.00
158.21%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,153.00
324.00
829.00
255.86%
Profit Available for appropriations
1,321.00
394.00
927.00
235.28%
Appropriations
1,321.00
394.00
927.00
235.28%
Equity Dividend (%)
267.5%
40%
227.50
Earnings Per Share
15.08
8.16
6.92
84.80%
Profit And Loss - Net Sales
Net Sales 745.76 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 17.09% vs 2.09% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 230.17 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 17.73% vs -4.93% in Mar 2025

Profit And Loss - Interest
Interest 3.73 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -19.41% vs 12.40% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 173.61 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 29.58% vs -2.17% in Mar 2025